In this episode, Danielle and I also explore the complex decisions BRCA mutation carriers face when it comes to hormone replacement therapy (HRT). Our conversation touches on the fears, uncertainties, and lived experiences that shape medical decision-making—especially around BRCA2.
Before you listen, I want to note an important correction: during this conversation, we spoke about HRT as if it were more dangerous for BRCA2 carriers. That statement was inaccurate. Current evidence, including guidance from the North American Menopause Society, does not support higher risk specifically for BRCA2. The conversation remains here as a reflection of the very real emotional landscape that many of us encounter, but I encourage you to review the science directly and to discuss your options with your healthcare team.
You can read the NAMS Practice Pearl "Use of Systemic Hormone Therapy in BRCA Mutation Carriers" here:
https://pubmed.ncbi.nlm.nih.gov/27504919/
This podcast is created from the perspective of a licensed therapist and focuses on the psychological, emotional, and relational aspects of living with hereditary cancer risk. It is not medical advice. Please consult your healthcare team when making medical decisions.